Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Ultrasensitive real-time PCR for the clinical management of visceral leishmaniasis in HIV-Infected patients.

Molina I, Fisa R, Riera C, Falcó V, Elizalde A, Salvador F, Crespo M, Curran A, López-Chejade P, Tebar S, Pérez-Hoyos S, Ribera E, Pahissa A.

Am J Trop Med Hyg. 2013 Jul;89(1):105-10. doi: 10.4269/ajtmh.12-0527. Epub 2013 Apr 29.

PMID:
23629932
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.

Sinha PK, van Griensven J, Pandey K, Kumar N, Verma N, Mahajan R, Kumar P, Kumar R, Das P, Mitra G, Flevaud L, Ferreyra C, Remartinez D, Pece M, Palma PP.

Clin Infect Dis. 2011 Oct;53(7):e91-8. doi: 10.1093/cid/cir521.

PMID:
21890763
[PubMed - indexed for MEDLINE]
Free Article
3.

Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.

Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P, Ouellette M.

Clin Infect Dis. 2009 Jan 15;48(2):e16-22. doi: 10.1086/595710.

PMID:
19093811
[PubMed - indexed for MEDLINE]
Free Article
4.

Relapsing visceral leishmaniasis in a HIV-1 infected patient with advanced disease.

Standaert D, Laurent F, Jonckheere S, Scheiff JM, Vandercam B, Yombi JC.

Acta Clin Belg. 2013 Mar-Apr;68(2):124-7.

PMID:
23967722
[PubMed - indexed for MEDLINE]
5.

Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature.

Antinori S, Calattini S, Longhi E, Bestetti G, Piolini R, Magni C, Orlando G, Gramiccia M, Acquaviva V, Foschi A, Corvasce S, Colomba C, Titone L, Parravicini C, Cascio A, Corbellino M.

Clin Infect Dis. 2007 Jun 15;44(12):1602-10. Epub 2007 May 7. Review.

PMID:
17516404
[PubMed - indexed for MEDLINE]
Free Article
6.

Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.

Molina I, Falcó V, Crespo M, Riera C, Ribera E, Curran A, Carrio J, Diaz M, Villar del Saz S, Fisa R, López-Chejade P, Ocaña I, Pahissa A.

J Antimicrob Chemother. 2007 Oct;60(4):837-42. Epub 2007 Aug 7.

PMID:
17684055
[PubMed - indexed for MEDLINE]
Free Article
7.

Comparison of parasitological, serological, and molecular tests for visceral leishmaniasis in HIV-infected patients: a cross-sectional delayed-type study.

Cota GF, de Sousa MR, de Freitas Nogueira BM, Gomes LI, Oliveira E, Assis TS, de Mendonça AL, Pinto BF, Saliba JW, Rabello A.

Am J Trop Med Hyg. 2013 Sep;89(3):570-7. doi: 10.4269/ajtmh.13-0239. Epub 2013 Jul 8.

PMID:
23836568
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.

ter Horst R, Collin SM, Ritmeijer K, Bogale A, Davidson RN.

Clin Infect Dis. 2008 Jun 1;46(11):1702-9. doi: 10.1086/587899.

PMID:
18419422
[PubMed - indexed for MEDLINE]
Free Article
9.

[Visceral leishmaniasis in patients with HIV infection].

Ribera E, Cucurull E, Ocaña I, Vallespí T, Gasser I, Juste C.

Enferm Infecc Microbiol Clin. 1995 Feb;13(2):73-9. Spanish.

PMID:
7711130
[PubMed - indexed for MEDLINE]
10.

Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis.

d'Ettorre G, Ceccarelli G, Carnevalini M, Forcina G, Zaffiri L, Massetti AP, Mastroianni CM, Vullo V.

Acta Trop. 2006 Aug;99(1):83-7. Epub 2006 Sep 11.

PMID:
16962979
[PubMed - indexed for MEDLINE]
11.

Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.

Laguna F, López-Vélez R, Pulido F, Salas A, Torre-Cisneros J, Torres E, Medrano FJ, Sanz J, Picó G, Gómez-Rodrigo J, Pasquau J, Alvar J.

AIDS. 1999 Jun 18;13(9):1063-9.

PMID:
10397536
[PubMed - indexed for MEDLINE]
12.

Real-time PCR in HIV/Trypanosoma cruzi coinfection with and without Chagas disease reactivation: association with HIV viral load and CD4 level.

de Freitas VL, da Silva SC, Sartori AM, Bezerra RC, Westphalen EV, Molina TD, Teixeira AR, Ibrahim KY, Shikanai-Yasuda MA.

PLoS Negl Trop Dis. 2011 Aug;5(8):e1277. doi: 10.1371/journal.pntd.0001277. Epub 2011 Aug 30.

PMID:
21912712
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.

Rihl M, Stoll M, Ulbricht K, Bange FC, Schmidt RE.

J Infect. 2006 Jul;53(1):e25-7. Epub 2005 Nov 7.

PMID:
16274744
[PubMed - indexed for MEDLINE]
14.

Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review.

Cota GF, de Sousa MR, Rabello A.

PLoS Negl Trop Dis. 2011 Jun;5(6):e1153. doi: 10.1371/journal.pntd.0001153. Epub 2011 Jun 7. Review.

PMID:
21666786
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Successful therapeutic splenectomy in an HIV patient with relapsing visceral leishmaniasis.

Alon D, Chowers M.

Int J STD AIDS. 2012 Apr;23(4):289-90. doi: 10.1258/ijsa.2009.009234.

PMID:
22581957
[PubMed - indexed for MEDLINE]
16.

Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis.

Bossolasco S, Gaiera G, Olchini D, Gulletta M, Martello L, Bestetti A, Bossi L, Germagnoli L, Lazzarin A, Uberti-Foppa C, Cinque P.

J Clin Microbiol. 2003 Nov;41(11):5080-4. Erratum in: J Clin Microbiol. 2004 Apr;42(4):1858.

PMID:
14605142
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.

Daher EF, Fonseca PP, Gerhard ES, Leitão TM, Silva Júnior GB.

J Parasitol. 2009 Jun;95(3):652-5. doi: 10.1645/GE-1678.1.

PMID:
19642802
[PubMed - indexed for MEDLINE]
18.

Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.

Ribera E, Ocaña I, de Otero J, Cortes E, Gasser I, Pahissa A.

Am J Med. 1996 May;100(5):496-501.

PMID:
8644760
[PubMed - indexed for MEDLINE]
19.

Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study.

Pintado V, Martín-Rabadán P, Rivera ML, Moreno S, Bouza E.

Medicine (Baltimore). 2001 Jan;80(1):54-73.

PMID:
11204503
[PubMed - indexed for MEDLINE]
20.

Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?

Medrano FJ, Hernández-Quero J, Jiménez E, Pineda JA, Rivero A, Sánchez-Quijano A, Velez ID, Viciana P, Castillo R, Reyes MJ, et al.

AIDS. 1992 Dec;6(12):1499-503.

PMID:
1362880
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk